Defense Health Agency Contracting Activity - DHACA
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award
DoW Amyotrophic Lateral Sclerosis Research Program, Clinical Outcomes and Biomarkers Award is a funding opportunity from Defense Health Agency Contracting Activity - DHACA, closing September 30, 2026.
Overview
Summary: The fiscal year 2026 (FY26) Amyotrophic Lateral Sclerosis Research Program (ALSRP) Clinical Outcomes and Biomarkers Award (COBA) supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in amyotrophic lateral sclerosis (ALS). Projects can be relevant to a…